Ladenburg Thalmann downgraded its rating on Response Genetics RGDX from Buy to Neutral. At the same time, the rating agency removed its price target on the company's stock. Its previous price target was $3.50. On Monday, RGDX closed the day at $2.49.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
